BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents. Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies. Leveraging our decades of experience in all stages of diagnostic development for the right solutions the first time.
Serving the Science of Diagnostics
BBI Solutions has served the global diagnostics industry for over 50 years
Our range of immuno-diagnostics reagents includes human antigens, antibodies, gold nanoparticles and conjugates, enzymes, and serum and plasma products.Learn more
A unique combination of custom antibody development, lateral flow assay development and manufacturing services ensures we can support you from concept to commercialisation.Learn more
BBI Solutions’ patented Novarum™ technology transforms a smartphone into a diagnostic test reader, allowing users to read and share rapid test results from the Point of Care.Learn more
We are proud to offer a comprehensive suite of reagents for your diagnostic needs. Discover our collection of reagents covering a comprehensive range of biomarkers and applications for the IVD market, life sciences,cell culture and beyond.Learn more
BBI have a significant and growing suite of IVD reagents for use in the development of diagnostics immunoassays for infectious diseases, for both common and emerging pathogens.Learn more
Autoimmune and Inflammation
Our autoimmune product portfolio has numerous applications as capture or control material in immunodiagnostic assays such as ELISA’s, CLIA & lateral flow, as well as in quality assurance control manufacture.Learn more
Our broad portfolio of cardiac antibodies and antigens support the development of assays that aid diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndromes.Learn more
BBI offers a broad portfolio of reagents to across enzymes, antigens and antibodies products to support our customers to deliver diagnostic solutions for one of the growing healthcare challenges of the 21st century.Learn more
Our unique combination of custom antibody development, lateral flow assay development and manufacturing services, signal enhancement technology and our smartphone reader technology are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.Learn more
Lateral Flow Services
Are you looking to outsource your lateral flow test development? We understand that getting a fast, accurate result is critical. Whether you are looking to improve an existing assay or develop a new assay, we offer a partnership approach to deliver robust and reliable tests ready for the global market.Learn more
We offer in vitro cell culture production of monoclonal antibody in roller bottles. Our cGMP facility can accommodate 1L to 100L volumes generating milligram to gram quantities of antibody. Cell lines can be produced in our standard hybridoma media or in custom media formulations provided by the customer.Learn more
BBI Solutions has over 25 years’ expertise working with customers and partners to develop and manufacture high quality proteins for a diverse range of applications with our Custom Protein Service.Learn more
One of the most important factors in the development of a reliable assay is the quality of the gold conjugate. At BBI Solutions, we use the highest quality grades of gold nanoparticles and apply our unique conjugation protocol to deliver an optimised product that meets the demands of your assay.Learn more
We offer custom monoclonal and polyclonal antibody development. services. Out highly experienced team will support you at every stage of the project. You define your immunoassay goals; let us develop the right antibodiesLearn more
BBI Solutions are revolutionising point of care testing. Our patented Novarum™️ technology transforms a smartphone into a diagnostic test reader, empowering users to read and share the results of rapid tests from the point of care.
Our highly trained team will work with you to develop a bespoke mobile app that meets your specific test needs. Data is then shared to a secure server for evaluation.
Accuracy, connectivity and ease of use make the Novarum™️ smartphone diagnostic platform invaluable for a variety of sectors, including medical, veterinary, defence, agricultural and environmental testing.Learn more
What is Novarum?
Our innovative Novarum mobile diagnostic platform overcomes barriers to point-of-care testing transforming a smartphone into a workflow movement tool enabling rapid diagnostics.Learn more
Novarum Sector Applications
The Novarum™ diagnostic platform has been designed for almost any test where the result is normally read by the human eye. Accuracy, connectivity and ease of use make the Novarum Reader invaluable for medical, veterinary, defence, agricultural and environmental testing.Learn more
Diagnostic App Development
Every Novarum project starts with our team gaining a deep understanding your assay/product, the target end user for your test and how a mobile solution helps differentiate your product’s value proposition.Learn more
Working with customers and partners to develop and manufacture enzymes
Lateral flow tests every year use our gold nanoparticles
Test strips contain our Glucose Oxidase for Blood Glucose Monitoring
Assay capacity annually with batch sizes from 5k to 100k
The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.
Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.
Novarum™ technology transforms a smartphone into a diagnostic test reader, empowering users to read and share the results of rapid tests from the point of care. Our pioneering technology can be used by anyone, anywhere, with minimal training: connecting patients and doctors, field workers, lab researchers and primary care clinicians to specialist practices as part of a mobile eco-system.